Pneumatosis Intestinalis and Portal Venous Gas Without Bowel Ischemia in a Patient Treated with Irinotecan and Cisplatin

  • David Kung
  • Daniel T Ruan
  • Rodney K. Chan
  • Melissa L. Ericsson
  • Mandeep S. Saund
Article

Abstract

Pneumatosis intestinalis and gas within the portal venous system are findings predictive of bowel ischemia. The etiologies of these alarming radiographic signs are diverse and not all causes require emergent surgical intervention. The combination of pneumatosis intestinalis, portal venous gas, and acidosis typically portends bowel ischemia and inevitable necrosis. This case report is the first description of benign pneumatosis and portal venous gas secondary to irinotecan and cisplatin.

Keywords

Pneumatosis intestinalis Portal venous gas Irinotecan 

References

  1. 1.
    Schulze CG, Blum U, Haag K (1995) Hepatic portal venous gas: imaging modalities and clinical significance. Acta Radiol 36:377–380PubMedCrossRefGoogle Scholar
  2. 2.
    Kernagis LY, Levine MS, Jacobs JE (2003) Pneumatosis intestinalis in patients with ischemia: correlation of CT findings with viability of the bowel. AJR Am J Roentgenol 180:733–736PubMedGoogle Scholar
  3. 3.
    Rha SE, Ha HK, Lee SH, Kim JH, Kim JK, Kim JH, Kim PN, Lee MG, Auh YH (2000) CT and MR imaging findings of bowel ischemia from various primary causes. Radiographics 20:29–42PubMedGoogle Scholar
  4. 4.
    Galm O, Fabry U, Adam G, Osieka R (2001) Pneumatosis intestinalis following cytotoxic or immunosuppressive treatment. Digestion 64:128–132PubMedCrossRefGoogle Scholar
  5. 5.
    Peloponissios N, Halkic N, Pugnale M, Jornod P, Nordback P, Meyer A, Gillet M (2003) Hepatic portal gas in adults. Arch Surg 138:1367–1370PubMedCrossRefGoogle Scholar
  6. 6.
    Knechtle SJ, Davidoff AM, Rice RP (1990) Pneumatosis intestinalis: surgical management and clinical outcome. Ann Surg 212:160–165PubMedCrossRefGoogle Scholar
  7. 7.
    Liebman PR, Patten MT, Manny J, Benfield JR, Hechtman HB (1978) Hepatic-portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg 187:281–287PubMedCrossRefGoogle Scholar
  8. 8.
    Griffiths DM, Gough MH (1986) Gas in the hepatic portal veins. Br J Surg. 73:172–176PubMedCrossRefGoogle Scholar
  9. 9.
    Wiesner W, Mortele KJ, Glickman JN, Ji H, Ros PR (2001) Pneumatosis intestinalis and portomesenteric venous gas in intestinal ischemia: correlation of CT findings with severity of ischemia and clinical outcome. AJR Am J Roentgenol. 177:1319–1323PubMedGoogle Scholar
  10. 10.
    Alimonti A, Gelibter A, Pavese I, Satta F, Cognetti F, Ferretti G, Rasio D, Vecchione A, Di Palma M (2004) New approaches to prevent intestinal toxicity of irinotecan-based regimens. Cancer Treat Rev 30:555–562PubMedCrossRefGoogle Scholar
  11. 11.
    Rothenberg M (2001) Irenotecan (CPT-11): recent developments and future directions–colorectal cancer and beyond. Oncologist 6:66–80PubMedCrossRefGoogle Scholar
  12. 12.
    Van Huyen JPD, Bloch F, Attar A, Levoir D, Kreft C, Molina T, Bruneval P (1998) Duffuse mucosal damage in the large intestine associated with irinotecan. Dig Dis Sci 43:2649–2651PubMedCrossRefGoogle Scholar
  13. 13.
    Araki E, Ishikawa M, Iigo M, Koide T, Itabashi M, Hoshi A (1993) Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11. Jpn J Cancer Res 84:697–702PubMedGoogle Scholar
  14. 14.
    Sandmeier D, Chaubert P, Bouzourene H (2005) Irinotecan-induced colitis. Int J Surg Pathol 13:215–218PubMedCrossRefGoogle Scholar
  15. 15.
    Fuertes MA, Castilla J, Alonso C, Pérez JM (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10:257–266Google Scholar
  16. 16.
    Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. New Engl J Med 346:85–91PubMedCrossRefGoogle Scholar
  17. 17.
    Tan HL, Tantoco JG, Ee MZ (2007) The role of diagnostic laparoscopy in micropremmies with suspected necrotizing enterocolitis. Surg Endosc 21:485–487PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • David Kung
    • 1
  • Daniel T Ruan
    • 1
  • Rodney K. Chan
    • 1
  • Melissa L. Ericsson
    • 2
  • Mandeep S. Saund
    • 1
  1. 1.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA
  2. 2.Western Connecticut State UniversityDanburyUSA

Personalised recommendations